Lucine is a technology company.
Lucine has raised $7.0M across 1 funding round.
Lucine has raised $7.0M in total across 1 funding round.
Lucine has raised $7.0M in total across 1 funding round.
Lucine's investors include AQUITI Gestion, Atlas Venture, Highbury Group, Johnson & Johnson Innovation, Kurma Partners, SR One.
Leucine is a technology company specializing in AI-driven software solutions for pharmaceutical manufacturing, offering an integrated platform called Compliance Cloud that automates compliance, enhances safety, and optimizes production processes.[1][3][6] It serves pharmaceutical companies, biotech firms, and manufacturers across over 300 facilities in 10 countries, solving key challenges like paper-based record management, regulatory compliance, and production inefficiencies through real-time monitoring, digital twins, and AI-powered tools such as electronic batch manufacturing records (eBMR) and predictive analytics.[1][3][6] With strong growth momentum, Leucine has expanded from cleaning validation software to a comprehensive Manufacturing Execution System (MES), Quality Management System (QMS), and Laboratory Execution System (LES), empowering over 30 clients to achieve faster, audit-ready operations.[1][4][6]
Leucine was co-founded in 2019 by Vivek Gera (CEO, IIT Kanpur graduate with expertise in compliance consultancy and pharmaceutical process engineering) and Mustaq Singh (CPO, IIT Kharagpur alumnus with over a decade in product management and software for critical industries), though some records note earlier roots around 2016-2017 focused on cleaning validation automation.[3][4] The idea emerged from the founders' shared interests in chemicals, mathematics, and pharma challenges like contamination risks and manual compliance processes, which they addressed by digitizing workflows and integrating AI.[4] Early traction came from modernizing compliance for pharma firms in Bengaluru, India (headquarters), with rapid evolution to a New York presence and global adoption, marking pivotal growth through AI orchestration of people, processes, and systems.[1][3][5]
(Note: A separate EU project-named "LUCINE" focuses on digital therapeutics for chronic pain via smartphone-based pain measurement, but lacks overlap with Leucine's pharma manufacturing focus and appears distinct.[2])
Leucine rides the wave of AI-driven digital transformation in life sciences manufacturing, where regulatory pressures (e.g., FDA compliance) and supply chain demands amplify the need for automation amid a $441B+ global pharma market strained by inefficiencies.[1][2][6] Timing is ideal as post-pandemic biotech growth and labor shortages push digitization, with Leucine's tools addressing paper-to-digital gaps that slow production by weeks—aligning with industry shifts toward predictive analytics and Industry 4.0.[1][4] Market forces like rising AI adoption in GxP environments favor Leucine, influencing the ecosystem by enabling smaller biotechs to scale compliantly alongside giants, reducing contamination risks, and boosting overall drug quality and speed-to-market.[1][3][5]
Leucine is poised for accelerated expansion as AI matures in pharma, potentially capturing more market share through enhanced predictive tools and global partnerships amid tightening regulations and demand for resilient supply chains.[1][6] Trends like advanced LLMs, VR integration (inspired by adjacent innovations), and sustainability-focused manufacturing will shape its trajectory, evolving Leucine from compliance enabler to full-orchestration leader.[2][3] Its influence may grow by setting standards for audit-ready AI, directly tying back to revolutionizing pharma production for safer, faster drugs—positioning it as an essential partner in a high-stakes industry.[1][4]
Lucine has raised $7.0M across 1 funding round. Most recently, it raised $7.0M Seed in November 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2020 | $7.0M Seed | AQUITI Gestion, Atlas Venture, Highbury Group, Johnson & Johnson Innovation, Kurma Partners, SR One |